For the quarter ended June 2025, Sabra Healthcare (SBRA Quick QuoteSBRA - Free Report) reported revenue of $189.15 million, up 7.4% over the same period last year. EPS came in at $0.38, compared to $0.10 in the year-ago quarter.

The reported revenue represents a surprise of +1.98% over the Zacks Consensus Estimate of $185.47 million. With the consensus EPS estimate being $0.37, the EPS surprise was +2.7%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Sabra performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Interest and other income: $10.34 million versus $10.03 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change.
• Revenues- Rental and related revenues: $99.82 million versus $95.9 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.7% change.
• Revenues- Resident fees and services: $78.99 million compared to the $78.6 million average estimate based on two analysts. The reported number represents a change of +16.3% year over year.
• Net Earnings Per Share (Diluted): $0.27 compared to the $0.17 average estimate based on three analysts.

View all Key Company Metrics for Sabra here>>>

Shares of Sabra have returned -1.8% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.